Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Accord Healthcare | Icatibant | Icatibant Accord | 2021-07-16 | |||
BioCryst Pharmaceuticals | Berotralstat | Orladeyo | 2021-04-30 | $346.443 M | Q2/23-Q1/24 | |
Cipla | Icatibant | Icatibant | 2020-07-13 | |||
Dr Reddys Laboratories | Icatibant | Icatibant | 2020-10-05 | |||
Eugia Pharma Specialties | Icatibant | Icatibant | 2023-08-14 | |||
Fresenius Kabi | Icatibant | Icatibant | 2020-06-18 | |||
Glenmark Pharmaceuticals | Icatibant | Icatibant | 2021-05-21 | |||
Jiangsu Hansoh Pharmaceutical Group | Icatibant | Icatibant | 2020-03-09 | |||
Nang Kuang Pharmaceutical | Icatibant | Icatibant | 2020-12-16 | |||
Pharming | Conestat alfa | Ruconest | 2010-10-28 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|